Christine Brennan, Ph.D.
Christine Brennan, Ph.D.
Chief Business Officer
Prior to joining Vitae Pharmaceuticals, Dr. Brennan spent 4.5 years at Novartis Institutes for BioMedical Research, Inc. in the Strategic Alliances group in positions of increasing responsibility, including, most recently, as Executive Director and Head of Strategy & Operations. Prior to joining Novartis, Dr. Brennan served as Director of Business Development at the biopharmaceutical company, EnVivo Pharmaceuticals, Inc. Prior to EnVivo, she was Director at Fidelity Biosciences Group, a venture capital company. Prior to Fidelity she was a Strategic Planning Analyst and then promoted to Product Manager for Cardizem LA (hypertension drug) at Biovail Corporation. Prior to Biovail, Dr. Brennan was Scientific Analyst in the business development group at Cogent Neuroscience, Inc., a start-up biotechnology company. She received her Ph.D. in neuroscience from Dartmouth Medical School in 1995 and completed a postdoctoral fellowship at the National Institutes of Health in 1999.